At Melanoma Bridge congress in Naples we met Omid Hamid, Chief of Translational Research and Immunotherapy and Director of Melanoma Center at The Angeles Clinic and Research Institute. We asked him what’s new in melanoma treatment, expecially in the adjuvant setting.